Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy

BACKGROUND: Vaccination of mice with tumors treated with Doxorubicin promotes a T cell immunity that relies on dendritic cell (DC) activation and is responsible for tumor control in vaccinated animals. Despite Doxorubicin in combination with Cyclophosphamide (A/C) is widely used to treat breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernal-Estévez, David A., García, Oscar, Sánchez, Ramiro, Parra-López, Carlos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769526/
https://www.ncbi.nlm.nih.gov/pubmed/29334915
http://dx.doi.org/10.1186/s12885-017-3982-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769526/
https://www.ncbi.nlm.nih.gov/pubmed/29334915
http://dx.doi.org/10.1186/s12885-017-3982-1

Ejemplares similares